1. Delivery strategies for immune checkpoint blockade inhibitors 2. Delivery strategies for ex vivo and in vivo T-cell reprogramming 3. Delivery strategies for ex vivo and in vivo NK cell reprogramming 4. Delivery strategies for tumor-associated macrophage reprogramming 5. Reprogramming lymphocytes for tumor immunotherapy 6. Targeting tumor-associated neutrophils in immunotherapy 7. Targeting tumor-associated fibroblast in immunotherapy 8. Oncolytic viral particle delivery 9. Extracellular vesicles (exosomes) in tumor immunotherapy 10. Nucleic acid-based delivery and reprogramming for tumor immuno-oncology 11. CRISPR-based gene editing in cancer immunotherapy 12. Delivery strategies for glioma immunotherapy 13. Delivery strategies for STING agonists 14. Delivery strategies for cancer vaccine and immunoadjuvant 15. Targeted delivery and reprogramming myeloid-derived suppressor cells (MDSC) in cancer 16. Delivery of radio-immunotherapy for solid tumors 17. Delivery of photo-immunotherapy for cancer 18. Local immunotherapy of cancer and metastasis 19. Delivery strategies to overcome tumor immunotherapy resistance